A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017.
Ammar Awad | Reuters
Shares for Teva Pharmaceuticals could jump 31% from here after the company settles a spate of legal issues, according to Barclays.
Shares for Teva Pharmaceuticals could jump 31% from here after the company settles a spate of legal issues, according to Barclays.